Modifications of skeletal muscle ryanodine receptor type 1 and exercise intolerance in heart failure.
about
The Measurement of Reversible Redox Dependent Post-translational Modifications and Their Regulation of Mitochondrial and Skeletal Muscle FunctionTotal chemical synthesis, refolding, and crystallographic structure of fully active immunophilin calstabin 2 (FKBP12.6)Gestational diabetes is characterized by reduced mitochondrial protein expression and altered calcium signaling proteins in skeletal muscleAction potential-evoked calcium release is impaired in single skeletal muscle fibers from heart failure patients.Acute Dietary Nitrate Intake Improves Muscle Contractile Function in Patients With Heart Failure: A Double-Blind, Placebo-Controlled, Randomized Trial.Dietary Nitrate and Skeletal Muscle Contractile Function in Heart Failure.Muscle Weakness in Rheumatoid Arthritis: The Role of Ca2+ and Free Radical Signaling.Randomised feasibility trial into the effects of low-frequency electrical muscle stimulation in advanced heart failure patients.Diaphragm abnormalities in heart failure and aging: mechanisms and integration of cardiovascular and respiratory pathophysiology.Association of FK506 binding proteins with RyR channels - effect of CLIC2 binding on sub-conductance opening and FKBP binding.Ryanodine Receptor Structure and Function in Health and Disease.Limitations of skeletal muscle oxygen delivery and utilization during moderate-intensity exercise in moderately impaired patients with chronic heart failure.Ryanodine Receptor Calcium Leak in Circulating B-Lymphocytes as a Biomarker in Heart Failure.Skeletal muscle bioenergetics in aging and heart failure.Resistance exercise-induced muscle fatigue is not accompanied by increased phosphorylation of ryanodine receptor 1 at serine 2843.
P2860
Q26774769-82B8CCD5-F07D-41C6-85E5-A4E3FD0EE966Q27728121-C1CF2955-7C89-43B9-A015-944ED6FCD138Q28542951-ADE151BB-D574-42E7-9103-D631450E63F7Q34331682-DA1FDAA6-A6C9-4099-A817-4C91996AA42DQ36070401-6DF44380-CB0E-4F8B-B90A-D124F68D5381Q38857849-6FB88906-C202-4D25-81CA-4509DBA7D05CQ41688477-F0ECB40A-1DBF-4588-8A59-B32711090D92Q41905530-D7BBAEA8-B974-4A51-B9A4-EA6FB45A7BF5Q46576175-9E5EEF0E-5F5D-45A0-8372-B603CDA91B9DQ47709918-BFAAA5EF-1A45-4D82-99E8-E36BD1104CD4Q49721336-A65E79FB-1457-408A-A98D-36C1CD9BA041Q51436909-B4B84695-264F-4AFF-B9F7-DA9AB38E4A5FQ52339083-5200B277-2051-4443-A6B5-373116A40094Q54917997-9187746A-368A-4CED-A1B5-EBB74C127D39Q55514486-9083D70D-0BA2-4A40-9170-75D31DCD0780
P2860
Modifications of skeletal muscle ryanodine receptor type 1 and exercise intolerance in heart failure.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Modifications of skeletal musc ...... intolerance in heart failure.
@ast
Modifications of skeletal musc ...... intolerance in heart failure.
@en
type
label
Modifications of skeletal musc ...... intolerance in heart failure.
@ast
Modifications of skeletal musc ...... intolerance in heart failure.
@en
prefLabel
Modifications of skeletal musc ...... intolerance in heart failure.
@ast
Modifications of skeletal musc ...... intolerance in heart failure.
@en
P2093
P2860
P50
P1476
Modifications of skeletal musc ...... e intolerance in heart failure
@en
P2093
Andrew R Marks
Donna M Mancini
Lars H Lund
Michael Melin
Steven Reiken
P2860
P304
P356
10.1016/J.HEALUN.2013.06.026
P577
2013-09-01T00:00:00Z